Research Paper Volume 15, Issue 20 pp 11286—11297
STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
Figure 3. STK4-associated clinical pathology characteristics of patients with ccRCC (also called kidney renal clear cell carcinoma, KIRC). (A) The expression of STK4 is based on the tumor stage, tumor grade, and nodal metastasis status. (B) The ROC curve of STK4 in patients with ccRCC.